194 related articles for article (PubMed ID: 19670456)
1. Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts.
Dignam JJ; Huang L; Ries L; Reichman M; Mariotto A; Feuer E
Cancer; 2009 Nov; 115(22):5272-83. PubMed ID: 19670456
[TBL] [Abstract][Full Text] [Related]
2. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.
Malmgren JA; Calip GS; Atwood MK; Mayer M; Kaplan HG
Cancer; 2020 Jan; 126(2):390-399. PubMed ID: 31639221
[TBL] [Abstract][Full Text] [Related]
3. Improved estimates of cancer-specific survival rates from population-based data.
Howlader N; Ries LA; Mariotto AB; Reichman ME; Ruhl J; Cronin KA
J Natl Cancer Inst; 2010 Oct; 102(20):1584-98. PubMed ID: 20937991
[TBL] [Abstract][Full Text] [Related]
4. The Extent of Axillary Surgery Is Associated With Breast Cancer-specific Survival in T1-2 Breast Cancer Patients With 1 or 2 Positive Lymph Nodes: A SEER-Population Study.
Li S; Liu F; Chen K; Rao N; Xie Y; Su F; Zhu L
Medicine (Baltimore); 2016 Apr; 95(14):e3254. PubMed ID: 27057872
[TBL] [Abstract][Full Text] [Related]
5. Noncancer deaths in white adult cancer patients.
Brown BW; Brauner C; Minnotte MC
J Natl Cancer Inst; 1993 Jun; 85(12):979-87. PubMed ID: 8496983
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database.
Roberts MC; Miller DP; Shak S; Petkov VI
Breast Cancer Res Treat; 2017 Jun; 163(2):303-310. PubMed ID: 28243896
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Survival Outcomes Among Patients With Breast Cancer With Distant vs Ipsilateral Supraclavicular Lymph Node Metastases.
Pan H; Wang H; Qian M; Mao X; Shi G; Ma G; Yu M; Xie H; Ling L; Ding Q; Zhang K; Wang S; Zhou W
JAMA Netw Open; 2021 Mar; 4(3):e211809. PubMed ID: 33724394
[TBL] [Abstract][Full Text] [Related]
8. Life expectancy of colon, breast, and testicular cancer patients: an analysis of US-SEER population-based data.
Capocaccia R; Gatta G; Dal Maso L
Ann Oncol; 2015 Jun; 26(6):1263-1268. PubMed ID: 25735314
[TBL] [Abstract][Full Text] [Related]
9. Diminished survival in patients with inner versus outer quadrant breast cancers.
Gaffney DK; Tsodikov A; Wiggins CL
J Clin Oncol; 2003 Feb; 21(3):467-72. PubMed ID: 12560437
[TBL] [Abstract][Full Text] [Related]
10. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival.
Hu CY; Xing Y; Cormier JN; Chang GJ
Cancer; 2013 May; 119(10):1900-7. PubMed ID: 23408226
[TBL] [Abstract][Full Text] [Related]
11. Survival of lymph node-negative breast cancer patients in relation to number of lymph nodes examined.
Polednak AP
Ann Surg; 2003 Feb; 237(2):163-7. PubMed ID: 12560772
[TBL] [Abstract][Full Text] [Related]
12. Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancer.
Rose BS; Jiang W; Punglia RS
Breast Cancer Res Treat; 2015 Jul; 152(1):209-216. PubMed ID: 26041688
[TBL] [Abstract][Full Text] [Related]
13. Effect of implant vs. tissue reconstruction on cancer specific survival varies by axillary lymph node status in breast cancer patients.
Ouyang Q; Zhu L; Chen K; Su F
PLoS One; 2015; 10(2):e0118161. PubMed ID: 25692294
[TBL] [Abstract][Full Text] [Related]
14. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
[TBL] [Abstract][Full Text] [Related]
15. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
[TBL] [Abstract][Full Text] [Related]
16. Development of National Program of Cancer Registries SAS Tool for Population-Based Cancer Relative Survival Analysis.
Dong X; Zhang K; Ren Y; Wilson R; O'Neil ME
J Registry Manag; 2016; 43(2):63-73. PubMed ID: 27556840
[TBL] [Abstract][Full Text] [Related]
17. Second cancer, breast cancer, and cardiac mortality in stage T1aN0 breast cancer patients with or without external beam radiation therapy: a national registry study.
Ye JC; Yan W; Christos P; Nori D; Chao KS; Ravi A
Clin Breast Cancer; 2015 Feb; 15(1):54-9. PubMed ID: 25223278
[TBL] [Abstract][Full Text] [Related]
18. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival.
Cronin KA; Feuer EJ
Stat Med; 2000 Jul; 19(13):1729-40. PubMed ID: 10861774
[TBL] [Abstract][Full Text] [Related]
19. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
20. The lifetime risk of developing breast cancer.
Feuer EJ; Wun LM; Boring CC; Flanders WD; Timmel MJ; Tong T
J Natl Cancer Inst; 1993 Jun; 85(11):892-7. PubMed ID: 8492317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
